Multicentric reticulohistiocytosis with elevated cytokine serum levels

J Dermatol. 2011 Sep;38(9):905-10. doi: 10.1111/j.1346-8138.2010.01146.x. Epub 2011 Jun 9.

Abstract

Multicentric reticulohistiocytosis (MRH) is an uncommon non-Langerhans cell histiocytosis of unknown etiology. It is a multisystem disorder characterised by a papulonodular skin eruption, mainly in the extensor surfaces, and destructive polyarthritis. Histologically, either cutaneous lesions or the synovium show a dense dermal infiltrate of histiocytes and multinucleated giant cells with an eosinophilic granular material in the cytoplasm. In the immunohistochemical analysis these cells stain positively with monocyte/macrophage markers (CD68 and CD45), as well as with certain cytokines (tumor necrosis factor-α, interleukin 1β and interleukin 6). Moreover, recent reports suggest an osteoclastic nature of the infiltrating cells, as they stain strongly with osteoclast tissue lytic markers including tartrate-resistant acid phosphatase and cathepsin K. We report a case of MRH presenting with clinical features of dermatomyositis. Furthermore, the patient showed elevated cytokine serum levels that lowered after therapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cytokines / blood*
  • Dermatomyositis / drug therapy
  • Dermatomyositis / immunology
  • Dermatomyositis / pathology
  • Histiocytosis, Non-Langerhans-Cell / drug therapy
  • Histiocytosis, Non-Langerhans-Cell / immunology*
  • Histiocytosis, Non-Langerhans-Cell / pathology*
  • Humans
  • Male
  • Methotrexate / therapeutic use
  • Prednisone / therapeutic use
  • Skin Diseases / drug therapy
  • Skin Diseases / immunology*
  • Skin Diseases / pathology*

Substances

  • Cytokines
  • Prednisone
  • Methotrexate